€200m pharma plan for Cork frozen by Trump fears

Project stalled as Eli Lilly awaits further information about new president's plans for industry

12th February, 2017

Pharmaceutical giant Eli Lilly has delayed a €200 million investment in Cork amid fears of a clampdown on the pharmaceutical sector by the newly elected US president Donald Trump.

A number of sources in Cork have confirmed to The Sunday Business Post that the project has been stalled as Eli Lilly awaits further information about Trump’s plans for its industry.

The new investment would create hundreds of jobs.

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month, €19.99 Monthly thereafter

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Analysis: Watt’s waiving of pay rise gets ministers off the hook – for now

Health Aiden Corkery 4 hours ago

Analysis: Don’t expect fans to play ball with dead rubbers

Sport Emmet Ryan 5 hours ago

Analysis: Financial and political hurdles could block European Super League

Sport Emmet Ryan 1 day ago

Emer McLysaght: Dazed and confused in a new age of A&E